CSTL vs PLD · rev $187.2M vs P/E 27, rev $2.30B
Castle Biosciences Inc (CSTL) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported PLD revenue for 2026-03-31 was $2.30B. Net income was $982.0M. Revenue was up 2.0% from 2025-12-31 to 2026-03-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
CSTL currently screens at market cap $570.2M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the CSTL and PLD stock pages for the full models.
Not investment advice.